<?xml version="1.0" encoding="UTF-8"?>
<p id="Par42">Of the human samples obtained from indigenous cases in 2014, 22,450 (60.12%) underwent laboratory tests in hospitals, including 8337 (37.14%) with NS1 antigen positive and 11,037 (62.86%) with antibody positive (IgM\IgG) for the preliminary screening.</p>
